Trouble viewing email, open in web browser |
 |
| |
MammoSite® Multi-Lumen (MSML) Targeted Radiation Therapy
A clear leader in catheter based Accelerated Partial Breast Irradiation (APBI)
With more than 65,000 women treated since 2002, the Mammosite therapy delivers clinical confidence you can count on. This next generation technology allows clinicians to offer this treatment to a wider spectrum of patients who may not have qualified for single-lumen brachytherapy solutions.
|
|
| |
To learn more about the next generation of breast brachytherapy, visit Hologic at ASTRO 2012, Booth #3049. |
|
|
|
| Hologic and MammoSite are trademarks and/or registered trademarks of Hologic and/or its subsidiaries in the U.S. and/or other countries. This information is intended for medical professionals in the U.S. and other markets and is not intended as a product solicitation or promotion where such activities are prohibited. Because Hologic materials are distributed through websites, eBroadcasts and tradeshows, it is not always possible to control where such materials appear. For specific information on what products are available for sale in a particular country, write to womenshealth@hologic.com. |
EMB-00427 |
|
|